Introduction
Prevalence estimates indicate that influenza virus infections are common in the United States pig population. 1, 2, 3 Once influenza viruses are introduced into a herd, they may be maintained and continue to circulate. This continued circulation is likely due to the availability of susceptible animals in a population, such as neonatal pigs. 4 One measure to reduce the number of susceptible animals is through vaccination. Vaccination of breeding females is a common practice for influenza virus, with 70% of large farms in the United States vaccinating breeding females in 2006. 5 Vaccination of sows and gilts should not only provide active immunity to the breeding herd, but also passive immunity through maternal antibody transfer via colostrum to the progeny. Therefore, understanding the role of maternally derived immunity on the transmission of influenza virus in neonatal pig populations is crucial. The objective of this study was to assess the role of maternally derived immunity in reducing influenza virus transmission in neonatal pig populations.
Materials and methods
Sows from an influenza virus negative breeding herd were assigned to one of three treatment groups: homologous influenza virus vaccine (HO), heterologous influenza virus vaccine (HE), and no vaccine (NV). Sows within the respective treatment groups were vaccinated at 4-5 and 2-3 weeks pre-farrow with experimental killed influenza virus vaccines. The homologous vaccine was created using the H1N1 challenge virus for this study and the heterologous vaccine was created using a distinct H1N1 virus (86% HA gene nucleotide similarity with the challenge virus). Offspring of the vaccinated sows were confirmed to be seropositive to influenza virus and purchased for use in this study. For each of two or three replicates, 10 pigs (3-4 weeks of age) from each of the aforementioned treatment groups were challenged with influenza virus via direct contact with an experimentally infected pig that was introduced to each treatment group. The experimentally infected pigs were infected with the HO virus. Nasal swabs were collected daily for two weeks following direct contact challenge and tested for influenza virus RNA via RRT-PCR. 6 The transmission parameters (β), infectious period, and reproduction ratios (R) were estimated and compared between treatment groups. Clinical signs, macroscopic and microscopic lesions, and antibody titers were also assessed.
Results
All pigs in the HE and HO groups had detectable antibody titers to the respective vaccine antigens prior to direct contact challenge. Pigs in the NV group were seronegative prior to direct contact challenge. All contact pigs became infected in the HE and NV groups and the R estimates did not differ significantly at 7.8 (4.6-12.6) and 11.0 (6.9-16.8) , respectively. One pig in the HO group became infected following contact and the R estimate was significantly lower in the HO group at 0.84 (0.05-3.7) versus the HE and NV groups.
Discussion
Although the use of influenza virus vaccines is common, the impact of maternally derived immunity on influenza virus transmission and infection is not fully understood. This study indicates that vaccine induced maternal immunity may be able to reduce influenza virus transmission in population settings; however, the impact will depend on the priming antigen. This study also indicates that influenza virus will spread rapidly in non-immune pig populations.
